Exploring the journey of emodin as a potential neuroprotective agent: Novel therapeutic insights with molecular mechanism of action
Open Access
- 31 March 2022
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 149, 112877
Abstract
No abstract availableKeywords
This publication has 185 references indexed in Scilit:
- -Synuclein in Parkinson's DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- SIRT1 Activates MAO-A in the Brain to Mediate Anxiety and Exploratory DriveCell, 2011
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approachActa Neuropathologica, 2011
- Neurological diseases and painBrain, 2011
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's DiseaseNew England Journal of Medicine, 2009
- Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little?Neuron, 2009
- Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's diseaseBrain, 2009
- α-synuclein locus duplication as a cause of familial Parkinson's diseaseThe Lancet, 2004
- Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patientsMolecular Psychiatry, 2002
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998